follow-up study on the children resulting from these and control pregnancies found three malignancies among the exposed children while none were found among the control or non-exposed group. In order to place this observed tumor incidence in proper perspective, the radiation dose received by the exposed children needs to be evaluated. For this evaluation, information is needed on the maternal-fetal transport of iron and the distribution of the transported iron within the fetus.
We have obtained this information during the early stages of pregnancy, 8 to 22 weeks, from studies on pregnant women receiving therapeutic abortions, but this means of investigation does not provide information on the late stages in pregnancy. Also, because cf experimental difficulties, the therapeutic abortion studies provide information at only one point in time, about eighteen hours after administration of the iron tracer. In order to obtain information later in pregnancy and on iron transport timing, we have conducted studies in pregnant sheep which this paper describes. Results:
The amount of fetal-administered iron tracer transported to the ewe was undetectable. This agrees with information in the literature for other mammals. That is, iron transport across the placenta is unidirectional with very little or no transport to the maternal unit from the fetus. Also we found no detectable transfer of iron from one fetus to another when more than one fetus was present in utero.
From the early and closely spaced blood samples, the maternal and fetal plasma iron clearances were determined. Table I presents Iron concentration was over eight times higher than the placenta while the .maternal liver was only twice as high. This reflects the large red cell production activity of the fetal liver. For the maternal spleen, however, the stable iron concentration was over 13 times higher than the placenta while the fetal spleen was only about twice as high. The lower iron concentration in the fetal spleen reflects the small amount of erythrocyte sequestration in the fetal spleen because of its short life time relative to the ewe. Table IV shows the transport to the total fetus, fetal liver and 59 fetal spleen of the Fe tracer given intravenously to tha ewe. Only about one-half of one percent of the tracer given the ewe appeared in the fetus. The magnitude of the iron transport to the fetus is much lower for the sheep than for some other mammals such as mice, rabbits, and swine.
However, the distribution of the transferred iron within the fetal sheep, about one-fourth in the fetal liver, is similar to what has been found for other mammals. The consistently high stable iron concentration and radioactive iron incorporation for the fetal liver point to this organ as the major site of fetal red cell production. Using the modified sheep data, the total fetal radiation dose to the 34-36 week human fetus was estimated to be 25.1 rads per mCi. This is lower than the total fetal radiation dose of 35-40 rads per mCi for the 8-22 weeks human fetus that we estimated from our therapeutic abortions studies. The fetal liver dose which we estimated to be around 400 rads per mCi for the 8-22 week human fetus is only about one-sixth as much for the 34-36 week human fetus. The observed malignancies in the children 59 exposed to Fe in ufcero were only found in those exposed early in pregnancy. The lack of observed malignancies in the children exposed in the later gestational stages is consistent with the lower radiation doses estimated for these children. 
